IP Library › Assignment 028010/0212
Patent Assignment
Reel/Frame 028010/0212

Assignment of Assignor's Interest

Recorded: 2012-04-09 Pages: 3
Assignor
ERLANSON, DANIEL
Executed: 2011-01-04
Assignee
SUNESIS PHARMACEUTICALS, INC.
395 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property (1)
Heterocyclic Compounds Useful as PDK1 Inhibitors
Patent: 9,546,165 →
Application: 13/499,835 →
Publication: US 2012/0208819
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 9, 2012
From: ARNDT, JOSEPH; CHAN, TIMOTHY; GUCKIAN, KEVIN; KUMARAVEL, GNANASAMBANDAM
To: BIOGEN IDEC MA INC.
Reel/Frame 028010/0180 →
Assignment of Assignor's Interest Apr 9, 2012
From: BIOGEN IDEC MA INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 028013/0222 →
Change of Name Dec 9, 2021
From: SUNESIS PHARMACEUTICALS, INC.
To: VIRACTA THERAPEUTICS, INC.
Reel/Frame 058741/0187 →
Intellectual Property Security Agreement Jan 23, 2025
From: VIRACTA THERAPEUTICS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 070000/0010 →